nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—CYP2D6—Hydroxyurea—head and neck cancer	0.276	0.31	CbGbCtD
Mirabegron—ALB—Fluorouracil—head and neck cancer	0.214	0.24	CbGbCtD
Mirabegron—ABCB1—Vinblastine—head and neck cancer	0.104	0.116	CbGbCtD
Mirabegron—CYP2D6—Vinblastine—head and neck cancer	0.0977	0.11	CbGbCtD
Mirabegron—ABCB1—Docetaxel—head and neck cancer	0.0855	0.096	CbGbCtD
Mirabegron—CYP3A4—Vinblastine—head and neck cancer	0.0621	0.0698	CbGbCtD
Mirabegron—CYP3A4—Docetaxel—head and neck cancer	0.0512	0.0575	CbGbCtD
Mirabegron—Lung neoplasm malignant—Docetaxel—head and neck cancer	0.00933	0.085	CcSEcCtD
Mirabegron—Breast cancer—Docetaxel—head and neck cancer	0.00513	0.0467	CcSEcCtD
Mirabegron—Neoplasm—Vinblastine—head and neck cancer	0.00357	0.0325	CcSEcCtD
Mirabegron—Neoplasm—Hydroxyurea—head and neck cancer	0.00326	0.0297	CcSEcCtD
Mirabegron—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00293	0.0267	CcSEcCtD
Mirabegron—Breast disorder—Hydroxyurea—head and neck cancer	0.00236	0.0215	CcSEcCtD
Mirabegron—Infestation NOS—Hydroxyurea—head and neck cancer	0.00202	0.0184	CcSEcCtD
Mirabegron—Infestation—Hydroxyurea—head and neck cancer	0.00202	0.0184	CcSEcCtD
Mirabegron—Osteoarthritis—Fluorouracil—head and neck cancer	0.00188	0.0171	CcSEcCtD
Mirabegron—Blood pressure increased—Docetaxel—head and neck cancer	0.00187	0.0171	CcSEcCtD
Mirabegron—Neoplasm—Docetaxel—head and neck cancer	0.00169	0.0154	CcSEcCtD
Mirabegron—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00168	0.0153	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00151	0.0138	CcSEcCtD
Mirabegron—Hypertension—Vinblastine—head and neck cancer	0.00149	0.0136	CcSEcCtD
Mirabegron—Infestation NOS—Fluorouracil—head and neck cancer	0.00145	0.0132	CcSEcCtD
Mirabegron—Infestation—Fluorouracil—head and neck cancer	0.00145	0.0132	CcSEcCtD
Mirabegron—Atrial fibrillation—Docetaxel—head and neck cancer	0.00143	0.0131	CcSEcCtD
Mirabegron—Urinary tract infection—Fluorouracil—head and neck cancer	0.00141	0.0128	CcSEcCtD
Mirabegron—Sinusitis—Fluorouracil—head and neck cancer	0.00136	0.0124	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00133	0.0121	CcSEcCtD
Mirabegron—Rhinitis—Fluorouracil—head and neck cancer	0.00131	0.0119	CcSEcCtD
Mirabegron—Infection—Hydroxyurea—head and neck cancer	0.00128	0.0116	CcSEcCtD
Mirabegron—Skin disorder—Hydroxyurea—head and neck cancer	0.00125	0.0114	CcSEcCtD
Mirabegron—Breast disorder—Docetaxel—head and neck cancer	0.00123	0.0112	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00122	0.0111	CcSEcCtD
Mirabegron—Nasopharyngitis—Docetaxel—head and neck cancer	0.00122	0.0111	CcSEcCtD
Mirabegron—Constipation—Vinblastine—head and neck cancer	0.00121	0.011	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.0012	0.0109	CcSEcCtD
Mirabegron—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00115	0.0105	CcSEcCtD
Mirabegron—Dyspepsia—Hydroxyurea—head and neck cancer	0.00113	0.0103	CcSEcCtD
Mirabegron—Abdominal pain—Vinblastine—head and neck cancer	0.00111	0.0101	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00111	0.0101	CcSEcCtD
Mirabegron—Fatigue—Hydroxyurea—head and neck cancer	0.00111	0.0101	CcSEcCtD
Mirabegron—Constipation—Hydroxyurea—head and neck cancer	0.0011	0.01	CcSEcCtD
Mirabegron—Vision blurred—Fluorouracil—head and neck cancer	0.00107	0.00973	CcSEcCtD
Mirabegron—Infestation NOS—Docetaxel—head and neck cancer	0.00105	0.00954	CcSEcCtD
Mirabegron—Infestation—Docetaxel—head and neck cancer	0.00105	0.00954	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00104	0.00946	CcSEcCtD
Mirabegron—Asthenia—Vinblastine—head and neck cancer	0.00101	0.00921	CcSEcCtD
Mirabegron—Diarrhoea—Vinblastine—head and neck cancer	0.000965	0.00878	CcSEcCtD
Mirabegron—Rhinitis—Docetaxel—head and neck cancer	0.000943	0.00858	CcSEcCtD
Mirabegron—Dizziness—Vinblastine—head and neck cancer	0.000933	0.00849	CcSEcCtD
Mirabegron—Urinary tract disorder—Docetaxel—head and neck cancer	0.000929	0.00846	CcSEcCtD
Mirabegron—Connective tissue disorder—Docetaxel—head and neck cancer	0.000924	0.00841	CcSEcCtD
Mirabegron—Asthenia—Hydroxyurea—head and neck cancer	0.000923	0.0084	CcSEcCtD
Mirabegron—Urethral disorder—Docetaxel—head and neck cancer	0.000922	0.00839	CcSEcCtD
Mirabegron—Infection—Fluorouracil—head and neck cancer	0.00092	0.00837	CcSEcCtD
Mirabegron—Tachycardia—Fluorouracil—head and neck cancer	0.000903	0.00823	CcSEcCtD
Mirabegron—Erythema multiforme—Docetaxel—head and neck cancer	0.000889	0.0081	CcSEcCtD
Mirabegron—Headache—Vinblastine—head and neck cancer	0.000883	0.00804	CcSEcCtD
Mirabegron—Diarrhoea—Hydroxyurea—head and neck cancer	0.00088	0.00801	CcSEcCtD
Mirabegron—Eye disorder—Docetaxel—head and neck cancer	0.000879	0.008	CcSEcCtD
Mirabegron—Cardiac disorder—Docetaxel—head and neck cancer	0.000873	0.00795	CcSEcCtD
Mirabegron—Dizziness—Hydroxyurea—head and neck cancer	0.00085	0.00774	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000843	0.00768	CcSEcCtD
Mirabegron—Nausea—Vinblastine—head and neck cancer	0.000838	0.00763	CcSEcCtD
Mirabegron—Dyspepsia—Fluorouracil—head and neck cancer	0.000815	0.00742	CcSEcCtD
Mirabegron—Rash—Hydroxyurea—head and neck cancer	0.000811	0.00738	CcSEcCtD
Mirabegron—Dermatitis—Hydroxyurea—head and neck cancer	0.00081	0.00738	CcSEcCtD
Mirabegron—Headache—Hydroxyurea—head and neck cancer	0.000806	0.00734	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000799	0.00728	CcSEcCtD
Mirabegron—Back pain—Docetaxel—head and neck cancer	0.000792	0.00721	CcSEcCtD
Mirabegron—Nausea—Hydroxyurea—head and neck cancer	0.000764	0.00695	CcSEcCtD
Mirabegron—Urticaria—Fluorouracil—head and neck cancer	0.000735	0.0067	CcSEcCtD
Mirabegron—Palpitations—Docetaxel—head and neck cancer	0.000723	0.00659	CcSEcCtD
Mirabegron—Hypertension—Docetaxel—head and neck cancer	0.000707	0.00644	CcSEcCtD
Mirabegron—Arthralgia—Docetaxel—head and neck cancer	0.000697	0.00635	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000692	0.0063	CcSEcCtD
Mirabegron—Dry mouth—Docetaxel—head and neck cancer	0.000682	0.00621	CcSEcCtD
Mirabegron—Infection—Docetaxel—head and neck cancer	0.000664	0.00604	CcSEcCtD
Mirabegron—Pruritus—Fluorouracil—head and neck cancer	0.000655	0.00596	CcSEcCtD
Mirabegron—Tachycardia—Docetaxel—head and neck cancer	0.000652	0.00594	CcSEcCtD
Mirabegron—Skin disorder—Docetaxel—head and neck cancer	0.000649	0.00591	CcSEcCtD
Mirabegron—Diarrhoea—Fluorouracil—head and neck cancer	0.000633	0.00577	CcSEcCtD
Mirabegron—Dizziness—Fluorouracil—head and neck cancer	0.000612	0.00557	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000609	0.00554	CcSEcCtD
Mirabegron—Dyspepsia—Docetaxel—head and neck cancer	0.000588	0.00535	CcSEcCtD
Mirabegron—Rash—Fluorouracil—head and neck cancer	0.000584	0.00531	CcSEcCtD
Mirabegron—Dermatitis—Fluorouracil—head and neck cancer	0.000583	0.00531	CcSEcCtD
Mirabegron—Headache—Fluorouracil—head and neck cancer	0.00058	0.00528	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000577	0.00525	CcSEcCtD
Mirabegron—Fatigue—Docetaxel—head and neck cancer	0.000576	0.00524	CcSEcCtD
Mirabegron—Constipation—Docetaxel—head and neck cancer	0.000571	0.0052	CcSEcCtD
Mirabegron—Nausea—Fluorouracil—head and neck cancer	0.00055	0.00501	CcSEcCtD
Mirabegron—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000546	0.00497	CcSEcCtD
Mirabegron—Abdominal pain—Docetaxel—head and neck cancer	0.000528	0.00481	CcSEcCtD
Mirabegron—Asthenia—Docetaxel—head and neck cancer	0.000479	0.00436	CcSEcCtD
Mirabegron—Pruritus—Docetaxel—head and neck cancer	0.000473	0.0043	CcSEcCtD
Mirabegron—Diarrhoea—Docetaxel—head and neck cancer	0.000457	0.00416	CcSEcCtD
Mirabegron—Dizziness—Docetaxel—head and neck cancer	0.000442	0.00402	CcSEcCtD
Mirabegron—Rash—Docetaxel—head and neck cancer	0.000421	0.00384	CcSEcCtD
Mirabegron—Dermatitis—Docetaxel—head and neck cancer	0.000421	0.00383	CcSEcCtD
Mirabegron—Headache—Docetaxel—head and neck cancer	0.000419	0.00381	CcSEcCtD
Mirabegron—Nausea—Docetaxel—head and neck cancer	0.000397	0.00361	CcSEcCtD
